Intel: Chips Act subsidies may impede a return to former glory - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Intel: Chips Act subsidies may impede a return to former glory

US government funds risk reducing pressure on semiconductor group to improve its performance

The US has embarked on an ambitious and expensive project: rebooting a domestic manufacturing industry for leading-edge chips. A downturn in demand ratchets up the pressure.

Intel imagines the push will help it regain global dominance. It would not be the first time the hopes of the US chip giant have exceeded its prospects.

The US Chips Act puts more than $52bn up for grabs via a mishmash of loans, guarantees for third parties and direct funding. Money will arrive in the coming months.

Intel is expected to be one of the biggest beneficiaries. But semiconductor companies jostling for funds are aiming at a moving target. The US government has introduced extra conditions, including childcare provision and limiting investment in Chinese entities. Funds cannot be spent on buybacks and dividends. Some projects will need to share profits. 

Intel can find ways to tick those boxes. It helps that the US wants projects that contribute to America’s national security and reduce dependence on chips made in Taiwan. Unlike rival AMD, Intel designs and makes chips. 

Yet Intel’s stock is down 24 per cent since the Chips Act was signed into law last August. Falling demand for semiconductors is only one reason for this. The share price of rival AMD is down 15 per cent over the same period. 

Intel has a large, cumbersome corporate structure, reflecting its range of legacy businesses. It does not produce leading-edge chips. Last year, revenue fell by a fifth. It is expected to drop by the same amount this year. Net income margin has halved.

The company is, meanwhile, increasing capital spending to pay for new factories and designs. The figure is expected to climb from about 20 per cent of sales five years ago to the “low 30s” this year. Last month, Intel cut its dividend by two-thirds.

AMD’s net income margin has also fallen. Semiconductor demand is readjusting following high spending during the pandemic. But AMD has less onerous capex obligations. Its new Ryzen chips boast artificial intelligence capabilities. Margins are forecast to return to 21 per cent this year.

Subsidies have a tendency to reduce competitiveness rather than increase it. They could simply reduce pressure on Intel to improve its performance. If money was essential for a turnround, it should have started 10 years ago, when Intel was sitting on more cash than its rivals.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

英国生物技术公司新药降低量身定制式癌症疗法副作用

Autolus用于治疗急性淋巴细胞白血病的新型Car-T细胞疗法在美国获批,该疗法与癌细胞结合所需时间更短,因此副作用更小。

前保守党财政大臣告诫工党现任勿看衰英国前景

杰里米•亨特表示,英国在关键增长领域表现强劲,应该停止贬低自己。

Lex专栏:游戏机制造商在低迷市场中表现强劲

虽然游戏机老化通常意味着游戏公司收入持续下降,但多年未推出新产品的索尼和任天堂等游戏公司仍表现强劲。

为年度展望报告辩护

巴克兰:定期回顾投资框架以及进行经济和市场展望是一项良好的做法。

企业长寿的奥秘为何对投资者很重要

长寿公司除了具有凝聚力、宽容度和财务保守等特征外,几乎没有什么共同点。
1天前

特朗普上台能否解决加拿大经济疲软问题?

经济学家表示,来自美国的冲击可能会使该国经济摆脱麻木状态。
设置字号×
最小
较小
默认
较大
最大
分享×